AT & S Austria Technologie & Systemtechnik (ATS) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
3 Feb, 2026Executive summary
Revenue for the first three quarters of 2025/26 reached €1.314 billion, up 10% year-over-year, with EBITDA at €297 million and a margin of 23%.
EBIT improved to €34 million (3% margin) from a loss of €1 million, and operating free cash flow turned positive at €223 million from negative €357 million.
New contributions from Kulim and Hinterberg/Leoben sites supported growth, while efficiency programs and improved pricing drove profitability.
Market environment is stabilizing, though global dynamics and FX headwinds persist.
Management board reorganized to three members, with a new CFO and CTO joining.
Financial highlights
Q1-3 revenue increased 10% year-over-year to €1,314 million, with Q3 revenue at €468 million and EBITDA margin at 23%.
Net CAPEX reduced by 67% to €108 million, and operating free cash flow improved significantly.
Net debt decreased by 12% to €1,316 million, with a net debt/EBITDA ratio of 2.0.
Equity ratio declined to 20.8% from 23.3%, impacted by FX effects.
Cost-saving program achieved €130 million by Q3, expected to exceed €160 million by year-end.
Outlook and guidance
Full-year 2025/26 revenue guidance confirmed at €1.7 billion, with EBITDA margin around 23% and net CAPEX of about €200 million.
2026/27 revenue guidance is €2.1–2.4 billion, EBITDA margin 24–28%, and net debt/EBITDA below 3 (can be temporarily exceeded).
Equity ratio may temporarily fall below 20% assuming hybrid capital repayment.
Additional capacity ramping, especially from Kulim, expected to drive future growth.
CAPEX planned at €200 million for 2025/26, mainly for IC substrate expansion in Kulim.
Latest events from AT & S Austria Technologie & Systemtechnik
- Adjusted EBITDA margin rose to 27.6% despite revenue decline and net loss.ATS
Q1 20252 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue, EBITDA, and cash flow improved, but FX and supply chain risks persist.ATS
Q2 202616 Dec 2025 - Revenue up 3%, EBITDA margin at 26%, with major investments and cost savings; outlook cautious.ATS
Q4 202521 Nov 2025 - Revenue up 14.2% year-over-year, but net loss widened on FX and ramp-up costs.ATS
Q1 202616 Nov 2025 - Revenue and earnings fell amid price pressure, but mid-term growth targets are reaffirmed.ATS
Q2 202513 Jun 2025